Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q3 EPS of $0.06, $0.11 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $105.66 million versus the consensus estimate of $103.7 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.